Search research articles
Contact Us
Filters
Showing results (121-130 of 217) with videos related to
Page
of 22
Sort By:
The Journal of Rheumatology. Supplement
|
June 3, 2019
GRAPPA 2018 Project Report
Niti Goel, Oliver FitzGerald, Dafna D Gladman, et al.
The New England Journal of Medicine
|
June 12, 2014
Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis
Philip J Mease, Mark C Genovese, Maria W Greenwald, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
The Function of <i>Efhd1</i> <sup>+</sup> Telocytes in the Synovial Lymphatic System and Inflammatory-Erosive Arthritis
Yue Peng, H Mark Kenney, Andriy Kobryn, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 30, 2019
TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21<sup>+</sup>/CD23<sup>-</sup> B Cell Follicles Is Prevented with Anti-TNF Therapy
Emily K Wu, Zoe I Henkes, Brion McGowan, et al.
Rheumatology (Oxford, England)
|
October 3, 2017
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
Iain B McInnes, Philip J Mease, Christopher T Ritchlin, et al.
Arthritis Care & Research
|
April 5, 2017
Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J Mease, Chitra Karki, Jacqueline B Palmer, et al.
Arthritis Research & Therapy
|
March 17, 2018
Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Peter Nash, Philip J Mease, Iain B McInnes, et al.
The Journal of Rheumatology
|
June 17, 2017
Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry
Philip J Mease, Chitra Karki, Jacqueline B Palmer, et al.
Arthritis and Rheumatism
|
February 1, 2007
Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial
Dafna D Gladman, Philip J Mease, Christopher T Ritchlin, et al.
Nature Reviews. Rheumatology
|
November 11, 2016
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
Laure Gossec, Laura C Coates, Maarten de Wit, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 217) with videos related to
Sort By:
Page
of 22
The Journal of Rheumatology. Supplement
|
June 3, 2019
GRAPPA 2018 Project Report
Niti Goel, Oliver FitzGerald, Dafna D Gladman, et al.
The New England Journal of Medicine
|
June 12, 2014
Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis
Philip J Mease, Mark C Genovese, Maria W Greenwald, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
The Function of <i>Efhd1</i> <sup>+</sup> Telocytes in the Synovial Lymphatic System and Inflammatory-Erosive Arthritis
Yue Peng, H Mark Kenney, Andriy Kobryn, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 30, 2019
TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21<sup>+</sup>/CD23<sup>-</sup> B Cell Follicles Is Prevented with Anti-TNF Therapy
Emily K Wu, Zoe I Henkes, Brion McGowan, et al.
Rheumatology (Oxford, England)
|
October 3, 2017
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
Iain B McInnes, Philip J Mease, Christopher T Ritchlin, et al.
Arthritis Care & Research
|
April 5, 2017
Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J Mease, Chitra Karki, Jacqueline B Palmer, et al.
Arthritis Research & Therapy
|
March 17, 2018
Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Peter Nash, Philip J Mease, Iain B McInnes, et al.
The Journal of Rheumatology
|
June 17, 2017
Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry
Philip J Mease, Chitra Karki, Jacqueline B Palmer, et al.
Arthritis and Rheumatism
|
February 1, 2007
Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial
Dafna D Gladman, Philip J Mease, Christopher T Ritchlin, et al.
Nature Reviews. Rheumatology
|
November 11, 2016
Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations
Laure Gossec, Laura C Coates, Maarten de Wit, et al.
Page
of 22